Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Leramistat by Istesso for Idiopathic Pulmonary Fibrosis: Likelihood of Approval
Leramistat is under clinical development by Istesso and currently in Phase II for Idiopathic Pulmonary Fibrosis. According to GlobalData, Phase...
Data Insights
Leramistat by Istesso for Autoimmune Disorders: Likelihood of Approval
Leramistat is under clinical development by Istesso and currently in Phase I for Autoimmune Disorders. According to GlobalData, Phase I...